This must-attend event will bring together 400+ leading pharmaceutical and medical device litigators, in-house counsel, private practice attorneys, and members of the judiciary to examine emerging litigation trends, evolving MDL strategies, and high-stakes case developments shaping the year ahead.
We’re especially excited to have our own Lisa Baird speaking at the conference on “Putting the Offense in the Preemption Defense.”
Mike Salimbene will be presenting a breakout session, "Labeled as Carcinogens, Litigated as Cause: Building the Defense in Trace-Exposure Cancer Claims."
Steve McConnell will also be taking the stage for the roundtable "Innovative Tactics for Persuading Juries That Pharma and Med Device Companies Are Not Bad Actors."
